A B C D E F G H I J K L M N O P Q R S T U V W X Y Z #

BR27 29 BREAST CANCER AG  Serum

Test Code
BR27


Alias/See Also
BR27 Breast Tumor Marker


Preferred Specimen
Gold Top Tube


Specimen Stability
8 hours room temp


Clinical Significance
In vitro diagnostic test for the quantitative measurement of BR (CA27.29) in human serum intended for use as aid in monitoring patients previously treated for Stage II or Stage III breast cancer.  Serial testing or CA27.29 in the serum of patients who are clinically free of disease should be used in conjunction with other clinical methods used for the early detection of cancer recurrence.  The test is also intended for use as an aid in the management of breast cancer patients with metastatic disease by monitoring the progression or regression of disease in response to treatment.




The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.